Sangamo Therapeutics
SGMO
#9340
Rank
S$0.13 B
Marketcap
S$0.33
Share price
-4.66%
Change (1 day)
-66.09%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -S$0.15 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are S$32.87 Million. In 2024 the company made an earning of -S$0.13 Billion, an increase over its 2023 earnings that were of -S$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.15 Billion14.76%
2024 -S$0.13 Billion-17.27%
2023 -S$0.16 Billion-40.88%
2022 -S$0.26 Billion9.79%
2021 -S$0.24 Billion41.52%
2020 -S$0.17 Billion23.17%
2019 -S$0.14 Billion36.33%
2018 -S$98.12 Million36.89%
2017 -S$71.68 Million-22.32%
2016 -S$92.28 Million54.86%
2015 -S$59.59 Million75.62%
2014 -S$33.94 Million0.13%
2013 -S$33.89 Million
2011 -S$45.56 Million43.66%
2010 -S$31.72 Million28.52%
2009 -S$24.68 Million-23.55%
2008 -S$32.28 Million2.45%
2007 -S$31.51 Million19.5%
2006 -S$26.37 Million50.78%
2005 -S$17.49 Million75%
2004 -S$10 Million-33.25%
2003 -S$14.97 Million-62.27%
2002 -S$39.68 Million102.82%
2001 -S$19.56 Million23.21%
2000 -S$15.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$42.66 B-30,874.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$11.41 B-8,332.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$1.97 B-1,527.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-S$3.2 Billion 2,203.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$12.45 B-9,085.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$28.51 B-20,666.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$0.73 B-628.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.61 B-542.54%๐Ÿ‡บ๐Ÿ‡ธ USA